BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17018683)

  • 1. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.
    Assaf C; Gellrich S; Whittaker S; Robson A; Cerroni L; Massone C; Kerl H; Rose C; Chott A; Chimenti S; Hallermann C; Petrella T; Wechsler J; Bagot M; Hummel M; Bullani-Kerl K; Bekkenk MW; Kempf W; Meijer CJ; Willemze R; Sterry W
    J Clin Pathol; 2007 Sep; 60(9):981-9. PubMed ID: 17018683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.
    Savoia P; Fierro MT; Novelli M; Quaglino P; Verrone A; Geuna M; Bernengo MG
    Br J Dermatol; 1997 Dec; 137(6):966-71. PubMed ID: 9470917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
    Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
    Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
    Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
    Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CD56-positive 'natural killer'/T-cell lymphoma].
    Bekkenk MW; Willemze R
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1524-5. PubMed ID: 11569462
    [No Abstract]   [Full Text] [Related]  

  • 9. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
    Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
    Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
    Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course.
    Mraz-Gernhard S; Natkunam Y; Hoppe RT; LeBoit P; Kohler S; Kim YH
    J Clin Oncol; 2001 Apr; 19(8):2179-88. PubMed ID: 11304770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
    Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
    Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiodestruction and tissue necrosis of skin-involving CD56+ NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins.
    Takeshita M; Yamamoto M; Kikuchi M; Kimura N; Nakayama J; Uike N; Daimaru H; Sawada H; Okamura T
    Am J Clin Pathol; 2000 Feb; 113(2):201-11. PubMed ID: 10664622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
    Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
    Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant lymphoma of the skin].
    Burg G; Dommann S; Dummer R
    Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.